Research ArticleTheranostics
Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma: 64Cu- and 225Ac-Labeled FAPI-04 in Pancreatic Cancer Xenograft Mouse Models
Tadashi Watabe, Yuwei Liu, Kazuko Kaneda-Nakashima, Yoshifumi Shirakami, Thomas Lindner, Kazuhiro Ooe, Atsushi Toyoshima, Kojiro Nagata, Eku Shimosegawa, Uwe Haberkorn, Clemens Kratochwil, Atsushi Shinohara, Frederik Giesel and Jun Hatazawa
Journal of Nuclear Medicine April 2020, 61 (4) 563-569; DOI: https://doi.org/10.2967/jnumed.119.233122
Tadashi Watabe
1Department of Nuclear Medicine and Tracer Kinetics, Graduate School of Medicine, Osaka University, Osaka, Japan
2Institute for Radiation Sciences, Osaka University, Osaka, Japan
Yuwei Liu
1Department of Nuclear Medicine and Tracer Kinetics, Graduate School of Medicine, Osaka University, Osaka, Japan
Kazuko Kaneda-Nakashima
2Institute for Radiation Sciences, Osaka University, Osaka, Japan
3Core for Medicine and Science Collaborative Research and Education, Project Research Center for Fundamental Sciences, Graduate School of Science, Osaka University, Osaka, Japan
Yoshifumi Shirakami
2Institute for Radiation Sciences, Osaka University, Osaka, Japan
Thomas Lindner
4Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany
Kazuhiro Ooe
1Department of Nuclear Medicine and Tracer Kinetics, Graduate School of Medicine, Osaka University, Osaka, Japan
2Institute for Radiation Sciences, Osaka University, Osaka, Japan
Atsushi Toyoshima
2Institute for Radiation Sciences, Osaka University, Osaka, Japan
3Core for Medicine and Science Collaborative Research and Education, Project Research Center for Fundamental Sciences, Graduate School of Science, Osaka University, Osaka, Japan
Kojiro Nagata
5Radioisotope Research Center, Institute for Radiation Sciences, Osaka University, Osaka, Japan
Eku Shimosegawa
2Institute for Radiation Sciences, Osaka University, Osaka, Japan
6Department of Molecular Imaging in Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan
Uwe Haberkorn
4Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany
7Clinical Cooperation Unit of Nuclear Medicine, DKFZ, Heidelberg, Germany
8Translational Lung Research Center Heidelberg, German Center for Lung Research (DZL), Heidelberg, Germany
Clemens Kratochwil
4Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany
Atsushi Shinohara
2Institute for Radiation Sciences, Osaka University, Osaka, Japan
9Department of Chemistry, Graduate School of Science, Osaka University, Osaka, Japan; and
Frederik Giesel
2Institute for Radiation Sciences, Osaka University, Osaka, Japan
4Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany
Jun Hatazawa
2Institute for Radiation Sciences, Osaka University, Osaka, Japan
10Research Center for Nuclear Physics, Osaka University, Osaka, Japan
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 61, Issue 4
April 1, 2020
Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma: 64Cu- and 225Ac-Labeled FAPI-04 in Pancreatic Cancer Xenograft Mouse Models
Tadashi Watabe, Yuwei Liu, Kazuko Kaneda-Nakashima, Yoshifumi Shirakami, Thomas Lindner, Kazuhiro Ooe, Atsushi Toyoshima, Kojiro Nagata, Eku Shimosegawa, Uwe Haberkorn, Clemens Kratochwil, Atsushi Shinohara, Frederik Giesel, Jun Hatazawa
Journal of Nuclear Medicine Apr 2020, 61 (4) 563-569; DOI: 10.2967/jnumed.119.233122
Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma: 64Cu- and 225Ac-Labeled FAPI-04 in Pancreatic Cancer Xenograft Mouse Models
Tadashi Watabe, Yuwei Liu, Kazuko Kaneda-Nakashima, Yoshifumi Shirakami, Thomas Lindner, Kazuhiro Ooe, Atsushi Toyoshima, Kojiro Nagata, Eku Shimosegawa, Uwe Haberkorn, Clemens Kratochwil, Atsushi Shinohara, Frederik Giesel, Jun Hatazawa
Journal of Nuclear Medicine Apr 2020, 61 (4) 563-569; DOI: 10.2967/jnumed.119.233122
Jump to section
Related Articles
Cited By...
- Fibroblast Activation Protein Inhibitor-Based Radionuclide Therapies: Current Status and Future Directions
- Fibroblast Activation Protein-Targeted Radioligand Therapy for Treatment of Solid Tumors
- Clinical Translation of Targeted {alpha}-Therapy: An Evolution or a Revolution?
- Clinical Translation of Targeted {alpha}-Therapy: An Evolution or a Revolution?
- Albumin Binder-Conjugated Fibroblast Activation Protein Inhibitor Radiopharmaceuticals for Cancer Therapy
- Synthesis, Preclinical Evaluation, and a Pilot Clinical PET Imaging Study of 68Ga-Labeled FAPI Dimer
- Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using 177Lu-FAP-2286: First-in-Humans Results
- Eliminating fibroblast activation protein-{alpha} expressing cells by photoimmunotheranostics
- FAPI PET/CT: Will It End the Hegemony of 18F-FDG in Oncology?
- The Latest Developments in Imaging of Fibroblast Activation Protein
- Three Distinct Stroma Types in Human Pancreatic Cancer Identified by Image Analysis of Fibroblast Subpopulations and Collagen
- Targeting Fibroblast Activation Protein: Radiosynthesis and Preclinical Evaluation of an 18F-Labeled FAP Inhibitor